Albeit its extension and the large list of references cited by the authors, we would like to call attention to two aspects we consider relevant. Firstly, parasitic intestinal diseases are not mentioned among those diseases whose risk of transmission is increased in a collective daycare environment. We could not find adequate reason for this omission, since the authors mention dermatoses caused by ectoparasites, such as scabies and pediculosis.
In 2005, 4 our group published a study demonstrating that 1-to 5-year-old children who attend daycare are 1.5 times more likely to have intestinal parasite infestations, when compared to controls of the same age, living in the same area.
The occurrence of parasitic intestinal diseases equated to 63% in the daycare group versus 41.3% in the control group (p < 0.01). According to a study published last year, We are aware of the efforts JPED have been making to enhance quality and visibility of the journal, hence our belief this is a relevant aspect to be discussed. We consider that the citation of articles and authors published in JPED increases its worldwide visibility. This is the case to ask if regarding "infections and daycare", has Jornal de Pediatria been forgotten or has it forgotten the theme? We want to thank Prof. Gurgel and Prof. Correia for their interest and pertinent comments on our article. Their comments give us the opportunity to broaden the discussion and also clarify some issues related to our paper.
With regard to the parasitic intestinal diseases, they were not included in our study because emphasis was given to diarrheal disease as a syndrome, since its clinical manifestation increases the risk of dissemination of the agent. Priority of notifiable diseases over other diseases has also contributed to our decision. On the other hand, our study was based on the diseases listed in which two types of phototherapy using different light sources were evaluated. We believe that this is the first published Brazilian study testing equipment in which LEDs were used that employ LEDs. We really like the detailed description of the radiation monitor, information on its wavelength range and on the spectrum of the light sources used. We consider that mention of these data and standardization of the measurements are essential for understanding and evaluating results in phototherapy. We would like to address some comments we consider pertinent to the discussion.
In the results, the authors refer to the mean irradiance expressing values in µW/cm 2 /nm. We believe that they probably refer to the mean of irradiance measurements at the point of peak intensity. Another aspect regarding the results refers to the authors' report on the patients on Super LED phototherapy, who relapsed with elevated total bilirubin when withdrawn from treatment and needed to go back on phototherapy. To avoid controversy over efficacy of this type of treatment, the authors could have elaborated this in their discussion. This phototherapy system actually has a greater capacity of rapidly reduce bilirubinemia, which caused the withdrawal levels (not informed on the study) to occur before the patient had had a better glucuronidation capacity so he could have been able to suppress new increases..
Finally, we believe that the wider emission spectrum of the halogen lamp, unlike the explanation provided on the study, did not interfere in the results of the phototherapy. Of the light spectrum of 380 nm to 600 nm, only the range between 400
and 500 nm will be absorbed by bilirubin, thus determining its conversion into an isomer and a product of photooxidation. The decrease in values is actually attributed to the difference in the intensity rather than in the quality of irradiance.
We appreciate the authors' article and we do hope that we have contributed toward a better understanding of the data reported.
